“The Arab Company for Drug Industry and Medical Appliances (ACDIMA) was instituted in 1976 with a total capital of USD 300,000,000 invested by 17 governments of Arab Countries. In its establishment doctrine, ACDIMA’s Board of Directors approved a strategy that aims at boosting investments in diversified pharmaceutical projects of on-demand feasibility and unique value. With integrated-resources approach, ACDIMA seeks to stimulate investors to set up joint pharmaceutical projects that exploit advanced technologies in the Arab World. Our targeted operations span over 10 countries and are conducted through three business segments to broaden our economic contribution.” “Supporting new entrepreneurships while ensuring sustainable long-term growth and legacy business development will allow us reaping the fruits of our flourishing long-standing partnerships.”

 “The Arab Company for Drug Industry and Medical Appliances (ACDIMA) was instituted in 1976 with a total capital of USD 300,000,000 invested by 17 governments of Arab Countries. In its establishment doctrine, ACDIMA’s Board of Directors approved a strategy that aims at boosting investments in diversified pharmaceutical projects of on-demand feasibility and unique value. With integrated-resources approach, ACDIMA seeks to stimulate investors to set up joint pharmaceutical projects that exploit advanced technologies in the Arab World. Our targeted operations span over 10 countries and are conducted through three business segments to broaden our economic contribution.” “Supporting new entrepreneurships while ensuring sustainable long-term growth and legacy business development will allow us reaping the fruits of our flourishing long-standing partnerships.”